Erectile dysfunction in men with obstructive sleep apnea syndrome: A randomized study of the efficacy of sildenafil and continuous positive airway pressure

International Journal of Impotence Research

Volumn 16, Issue 3, 2004, Pages 256-260

  Perimenis, P ^a,c   Karkoulias, K ^b   Markou, S ^b   Gyftopoulos, K ^a   Athanasopoulos, A ^a   Barbalias, G ^a   Kiriazopoulou, V ^b   Spiropoulos, K ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Continuous positive airway pressure; Erectile dysfunction; Obstructive sleep apnea; Sildenafil; Sleep disorders

Indexed keywords

SILDENAFIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERECTILE DYSFUNCTION; HEADACHE; HOT FLUSH; HUMAN; MALE; PATIENT SATISFACTION; PENIS ERECTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL INTERCOURSE; SIDE EFFECT; SLEEP APNEA SYNDROME; TREATMENT OUTCOME;

COITUS; COMBINED MODALITY THERAPY; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; IMPOTENCE; MALE; PATIENT SATISFACTION; PIPERAZINES; PROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; VASODILATOR AGENTS;

EID: 3042742398     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901219     Document Type: Article

References (25)

1. Fanfulla F, Malaguti S, Montagna T et al. Erectile dysfunction in men with obstructive sleep apnea: an early sign of nerve involvement. Sleep 2000; 23: 775-781.
2. Guilleminault C et al. Sleep apnea syndrome due to upper airway obstruction. A review of 25 cases. Arch Intern Med 1977; 137: 296-300.
3. Hirshkowitz M, Karacan I, Gurakar A, Williams PI. Hypertension, erectile dysfunction, and occult sleep apnea. Sleep 1989; 12: 223-232.
4. Schmidt HS, Wise II HA. Significance of impaired penile tumescence and associated polysomnographic abnormalities in the impotent patient. J Urol 1981; 126: 348-352.
5. Pressman MR et al. Problems in the interpretetion of nocturnal penile tumescence studies: disruption of sleep by occult sleep disorders. J Urol 1986; 136: 595-598.
6. Lewis RD, Hatzichristou DG, Laumann E, McKinlay JB. Epidemiology and natural history of erectile dysfunction: risk factors including iatrogenic and ageing. In: Jardin A, Wagner G, Khoury S, Giuliano F, Goldstein I, Padma- Nathan H (eds). Recommendations of the First International Consultation on Erectile Dysfunction, cosponsored by the World Health Organization (WHO). Plymouth: Health Publication Ltd, 2000, pp 21-51.
7. Massberg S et al. Increased adhesion and aggregation of platelets lacking cyclic guanosine 3′-5′-monophosphate kinase J. J Exp Med 1999; 189: 1255-1263.
8. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndrome as risk factor for hypertension: population study. BMJ 2000; 320: 479-482.
9. Bolli R. Cardioprotective function of inducible nitric oxide synthesis and role of nitric oxide in myocardial ischaemia and preconditioning: an overview of a decade research. J Mol Cell Cardiol 2001; 33: 1897-1918.
10. Haight JSJ, Djupesland PG. Nitric oxide (NO) and obstructive sleep apnea (OSA). Sleep Breath 2003; 7: 53-61.
11. Malhotra A, White DP. Obstructive sleep apnoea. Lancet 2002; 360: 237-245.
12. Karacan I, Karatas M. Erectile dysfunction in sleep apnea and response to CPAP. J Sex Marit Ther 1995; 21: 239-247.
13. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages in Human Adults. US Government Printing Office: Washington, 1968.
14. Rosen RC et al. The International Index of Erectile Dysfunction (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
15. Shepard Jr JW et al. Relationship of ventricular ectopy to nocturnal oxygen desaturation in patients with chronic obstructive pulmonary disease. Am J Med 1995; 78: 28-34.
16. Duchna HW et al. Obstructive sleep apnea syndrome: a cardiovascular risk factor? Z Kardiol 2001; 90: 568-575.
17. Kato M et al. Impairment of endothelium dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607-2610.
18. Ip MS et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care 2000; 162: 2166-2171.
19. Schulz R et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000; 55: 1046-1051.
20. Aasebo U et al. Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long-term oxygen therapy. J Steroid Biochem Mol Biol 1993; 46: 799-803.
21. Goldstein I, et al, for the Sildenafil Study Group. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338: 1397-1404.
22. Montorsi F et al. Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies. Urology 1999; 53: 1011-1018.
23. Perimenis P et al. A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arterial erectile dysfunction. Int J Impot Res 2004; 16: 2-7.
24. Capelleri JC et al. Diagnostic evaluation of erectile function domain of the international index of erectile function. Urology 1999; 54: 346-351.
25. Heaton JPW, Hackett G, Savage D, Padley RJ. Patient choice is critical in managing erectile dysfunction. Eur Urol 2002; 1: 33-37.